Morningside Venture Investments, founded in 1986 by the Chan family, is a venture capital fund focused on Series C biotech companies. Based in Boston, Shanghai, and London, Morningside invests globally. Their team combines deep industry knowledge with strong local connections and a commitment to social responsibility. Notable investments include ENYO Pharma.
